Abstract: There are provided 5,6-dihydro-4H-dithieno[3,2-b:2?,3?-d]azepine derivatives(as defined in the disclosure) which are useful in the treatment of RSV infection and for the prevention of disease associated with RSV infection.
Type:
Grant
Filed:
April 7, 2017
Date of Patent:
April 21, 2020
Assignee:
PULMOCIDE LIMITED
Inventors:
Simon Fraser Hunt, Stuart Thomas Onions, Vladimir Sherbukhin, Euan Alexander Fraser Fordyce, Jennifer Claire Thomas, Peter John Murray, Matthew Stephen Coates, Daniel William Brookes, Kazuhiro Ito, Peter Strong
Abstract: The invention relates to aqueous suspension formulations of compounds, as defined in the specification and as represented by the compound of formula (I): and to their use in therapy.
Type:
Grant
Filed:
March 20, 2019
Date of Patent:
December 24, 2019
Assignee:
PULMOCIDE LIMITED
Inventors:
Thomas Christopher Colley, Kazuhiro Ito, Peter Strong, Mihiro Sunose, Matthew McConville
Abstract: There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (I)).
Type:
Grant
Filed:
March 11, 2019
Date of Patent:
November 12, 2019
Assignee:
PULMOCIDE LIMITED
Inventors:
Simon Fraser Hunt, Stuart Thomas Onions, Vladimir Sherbukhin, Euan Alexander Fraser Fordyce, Peter John Murray, Daniel William Brookes, Kazuhiro Ito, Peter Strong, Matthew Stephen Coates